Lower the interest rate on some of the other debt and have some spare coin. Good commercial move but not very sexy for SP IMO.
They had me getting excited.
I will be surprised if this CR boosts SP unless/until some other Announcements where Linc has an opportunity to commercialise an asset and needs the funds. no direct mention of wyoming R&D UCG trial or EOR and how that is to be funded...my gut is unreliable obviously.
PB mentions minimising 3rd party equity in sub-salt play or increased equity in commercial UCG joint ventures. The joint ventures possible are Exxaro, DTEK and GCL so far. In the Feb presentation the calendar says for UCG - Exxaro spec and commercial project B are happening in 2013 Q2 .... What is commercial project B I wonder and when in Q2 will we find out?
LNC Price at posting:
$2.39 Sentiment: Buy Disclosure: Held
